Acute severe respiratory syndrome coronavirus-2 treatment overview for pediatrics.

ABSTRACT:

Purpose of review

The novel severe respiratory syndrome coronavirus-2 (SARS-CoV-2) virus has caused a world-wide pandemic with devastating effects. Fortunately, most children display only mild-to-moderate symptoms, but there are a subset that will have severe symptoms warranting treatment. This review evaluates the current evidence for antiviral and anti-inflammatory treatment of acute SARS-COV-2 infections, including coronavirus disease 2019 in pediatrics.

Recent findings

Treatment recommendations continue to evolve with emerging results from clinical trials. Initial therapies were tailored to repurposed medications, and have now transitioned toward more specific antiviral therapy. In addition to specific antiviral therapy, there is also support to modulate the immune syste

SUBMITTER: Murphy ME 

PROVIDER: S-EPMC7861135 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature